Researchers at the University of Minnesota have developed YCT-529, a non-hormonal male birth control pill showing efficacy in ...

Clinical symptoms and signs are a bridge between biomedicine and traditional medicine [TM]. These can be associated with diseases incl. their diagnosis, pharmacological targets, and the use of ...

Research from the University of Minnesota College of Pharmacy, published in Communications Medicine, has laid the groundwork ...

A groundbreaking male birth control pill, YCT529, is being developed by researchers at the University of Minnesota in ...

While the FDA has approved over 20 different categories of contraceptives, only two are available for men to prevent ...

MINNEAPOLIS — The University of Minnesota College of Pharmacy released research Wednesday that lays the groundwork for the ...

Through this partnership, Pentec will act as a distribution and service provider for Luminopia, offering comprehensive support services to patients and providers. This includes navigating insurance to ...

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, ...

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their greatest lesson from 2024 ...

Paul Markovich, president of Blue Shield of California new parent Ascendiun, explains how the nonprofit company aims to ...